Company news
Cuprina Holdings (cayman) Limited (NASDAQ:CUPR) news
Cuprina Holdings (cayman) Limited news releases on 6ix. Latest, Oct 2, 2026: Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore…
Press releases & updates
Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group
October 2, 2026
Cuprina Holdings (Cayman) Limited Announces Closing of Underwriter’s Over-Allotment Option in Connection with Public Offering
September 29, 2026
Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering
September 16, 2026
Cuprina Holdings (Cayman) Limited Announces Pricing of $4.97 million Public Offering
September 16, 2026
Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product
June 15, 2026
Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements
June 12, 2026
Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing
May 29, 2026
Cuprina Holdings announces 1-for-8 Share Consolidation
May 22, 2026
Super Copper Appoints Andrés Encina as Country Manager, Chile
March 31, 2026
Super Copper Announces Initiation of Research Coverage by Baader Europe
March 17, 2026
Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board
March 10, 2026
Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth
December 9, 2025
Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
November 28, 2025
Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy
November 18, 2025
Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies
October 27, 2025
Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET
October 6, 2025
Cuprina Secures Exclusive Rights to Southeast Asia’s First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology
September 9, 2025
Cuprina Reaffirms Commitment to Shareholders and Patients Following Recent Stock Market Activity
August 18, 2025
Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market
July 21, 2025
Cuprina Provides Update on Research Studies with Three Leading Education Institutes
June 30, 2025
Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries
June 4, 2025
Cuprina Holdings Announces Closing of Underwriter’s Over-Allotment Option in Connection with Initial Public Offering
May 8, 2025
Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.
May 5, 2025
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
May 4, 2025
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
May 4, 2025